期刊文献+

改良性电抽搐治疗并发精神病性症状的抑郁症 被引量:1

Controlled Study of Modified Electro-convulsive Treatment for Depression Associated with Psychotic Symptoms
下载PDF
导出
摘要 目的:探讨合并改良电抽搐治疗(MECT)并发精神病性症状的抑郁症患者的临床疗效及安全性。方法:80例并发精神病性症状的抑郁症患者随机分为MECT组及对照组各40例,均给予抗抑郁剂治疗,MECT组加用MECT治疗;对照组加用利培酮治疗。治疗前后均行汉密尔顿抑郁量表(HAMD)、简明精神病量表(BPRS)及副反应量表(TESS)评定。结果:治疗第1周末时,MECT组HAMD总分及各因子分、BPRS总分与治疗前比较均明显下降,对照组在治疗第2周末时开始下降;第4周末时,MECT组显效率为75%,对照组为67.5%,2组显效率相近。TESS分值2组比较差异无显著性意义。结论:MECT治疗并发精神病性症状的抑郁症起效快,改善症状早,且安全。 Objective: To study the clinical effect and safety of modified electro-convulsive treatment (MECT) in combination with antidepressants for depression associated with psychotic symptoms, Methods: Eighty depression patients associated with psychotic symptoms were randomly divided into MECT group and and control group (n=40 in each group). Both two groups were treated by anti-depressive drugs. The patients in MECT group were subjected to MECT and those in control group were treated with risperidol. All patients were assessed by HAMD, BPRS and TESS before and after treatment. Results: The total scores and the scores of every factor of HAMA and BPRS were significantly reduced in MECT group at the end of first week after treatment as compared with those before treatment; In control group, the total scores and the scores of every factor of HAMA and BPRS were significantly decreased at second week after treatment. At the end of 4th week after treatment, the excellent effective rate was 75% and 67.5% in MECT group and control group respectively. There was no significant difference in TESS between two groups. Conclusion: MECT is safe and effective in treating depression associated with psychotic symptoms.
出处 《中国康复》 2008年第1期66-68,共3页 Chinese Journal of Rehabilitation
关键词 改良性电抽搐治疗 精神病性症状 抑郁症 Modified electro-convulsive treatment Psychotic symptoms Depression
  • 相关文献

参考文献8

  • 1Birkenhager TK, Van Den Broek WW, Mulder PG, et al. One-year outcome of psychotic depression after successful electroconvulsive therapy [J]. J ECT (S1095 -- 0680), 2005,21(4) :221--226.
  • 2Petrides G, Fink M, Husain MM, et al. ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE[J]. J ECT(S1095--0680),2001,17(4):244--253.
  • 3Husain MM, Rush AJ, Fink M. Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a consortium for research in ect (CORE) report[J]. J Clin Psychlatry(S1433 --1055), 2004,65(4):485--491.
  • 4Flint AJ, Rifat SL. The treatment of psychotic depression in later life: a comparison of pharmacotherapy and ECT [J]. Int J Geriatr Psychiatry(S0885--6230), 1998,13 (1) :23--28.
  • 5Nothdurfter C, Eser D, Schule C. The influence of concomitant neuroleptic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy[J]. World J Biol Psychiatry(S1562--2975), 2006,7(3) 162--170.
  • 6路英智,任清涛,田明萍.氟西汀联合利培酮治疗抑郁症的对照研究[J].中国行为医学科学,2003,12(1):47-48. 被引量:7
  • 7张明圆.精神科评定量表手册[M].长沙:湖南科学技术出版社,1993.34-41.
  • 8曹红军,范凤兰,尤海峰,张静,李德重.文拉法辛联合氯丙嗪治疗精神病性抑郁症的对照研究[J].中国行为医学科学,2003,12(5):530-532. 被引量:4

二级参考文献12

  • 1张继志.新型抗精神病药利培酮[J].国外医学(精神病学分册),1995,22(3):137-139. 被引量:39
  • 2Rvedolph RL, Entsuh R, Chitra R. A meta-analysis of the effects of venlafaxine on anxiety associated with depression [J ]. J Clin Psychophramacol, 1998,18 (2) : 136-144.
  • 3Rudolph RL, Fabre LF , Felghner JP, et al. A randomized,Placebo-controlled, Close-respanse trial of venlafaxine hydrochloride in the treatment of major depression [J]. J Clin Psychiatry,1988, 59(3) : 116-122.
  • 4Lecrubier Y, Bourin M, Moon CA, et al. Efficacy of venlafaxine in depressive illness in general Practice [ J ]. Acta Psychiatry Scand, 1997,95(6) :485-493.
  • 5Guelfi JD, White C, Hackett D, et al. Effectiveness of venlafaxine in patients hospitalized for major depression and melancholia [J]. J Clin Psychiatry, 1995, 56(10) :450-458.
  • 6Bolden-Watson C, Michelson E. Blockade by newly-developed antidepressant of biogenic amine Uptake into rat brain synaptosomes [J ]. Life Sci, 1993,52(12) : 1023-1025.
  • 7陆林,黄明生,孙学礼,杨彦春,李静,徐楠,季刚.国产万拉法新胶囊Ⅰ期临床耐受性试验[J].上海精神医学,1998,10(4):190-192. 被引量:30
  • 8翁史旻,王祖承,顾牛范,笪志民,李华芳,周自强,李鸣,梅其一,俞柏润,潘人伟.文拉法辛治疗抑郁症62例的多中心开放性研究[J].中国新药与临床杂志,2000,19(5):403-405. 被引量:26
  • 9逄晓云,贡沁燕.文拉法辛的药理学与临床应用[J].中国新药与临床杂志,2000,19(5):342-344. 被引量:85
  • 10林建荣,黄煜坤,余金龙,黄杰平,李洁仪.文拉法辛治疗抑郁症74例[J].中国新药与临床杂志,2000,19(5):375-377. 被引量:24

共引文献324

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部